Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Late disclosures of federal funding in US patents 

Author: Luis Gil Abinader

Date:  6/11/25

Language: English

Learn More: https://academic.oup.com/jlb/article/12/1/lsaf012/8160132?trk=feed_main-feed-card_feed-article-content&login=false

You might also enjoy

Private finance and the threat to global health

Read More »

Drug Dealing: Making Public Pharma Work

Read More »

Reclaiming drug discovery: why we need public pharma

Read More »

Sweden’s new antibiotic factory could serve as EU and NATO strategic asset

Read More »

Open drug pricing activist MSF signs secrecy pacts with Big Pharma

Read More »

FINALLY, THE PANDEMIC AGREEMENT!!! …… Many missed opportunities, but a beginning made

Read More »